» Articles » PMID: 15210714

A Truncated Isoform of C-Mpl with an Essential C-terminal Peptide Targets the Full-length Receptor for Degradation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Jun 24
PMID 15210714
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombopoietin and its cognate receptor c-Mpl are the primary regulators of megakaryopoiesis and platelet production. They also play an important role in the maintenance of hematopoietic stem cells. Here, we have analyzed the function of a truncated Mpl receptor isoform (Mpl-tr), which results from alternative splicing. The mpl-tr variant is the only alternate mpl isoform conserved between mouse and humans, suggesting a relevant function in regulating Mpl signaling. Despite the presence of a signal peptide and the lack of a transmembrane domain, Mpl-tr is retained intracellularly. Our results provide evidence that Mpl-tr exerts a dominant-negative effect on thrombopoietin-dependent cell proliferation and survival. We demonstrate that this inhibitory effect is due to down-regulation of the full-length Mpl protein. The C terminus of Mpl-tr, consisting of 30 amino acids of unique sequence, is essential for the suppression of thrombopoietin-dependent proliferation and Mpl protein down-regulation. Cathepsin inhibitor-1 (CATI-1), an inhibitor of cathepsin-like cysteine proteases, counteracts the effect of Mpl-tr on Mpl protein expression, suggesting that Mpl-tr targets Mpl for lysosomal degradation. Together, these data suggest a new paradigm for the regulation of cytokine receptor expression and function through a proteolytic process directed by a truncated isoform of the same receptor.

Citing Articles

A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms.

Hussain M, Das S, Kulkarni M, Laha S Cell Oncol (Dordr). 2024; 47(5):1607-1626.

PMID: 39283476 DOI: 10.1007/s13402-024-00988-w.


Single-cell gene and isoform expression analysis reveals signatures of ageing in haematopoietic stem and progenitor cells.

Mincarelli L, Uzun V, Wright D, Scoones A, Rushworth S, Haerty W Commun Biol. 2023; 6(1):558.

PMID: 37225862 PMC: 10209181. DOI: 10.1038/s42003-023-04936-6.


c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance.

Li F, Xiong Y, Yang M, Chen P, Zhang J, Wang Q Cell Death Dis. 2022; 13(10):869.

PMID: 36229456 PMC: 9561678. DOI: 10.1038/s41419-022-05315-5.


Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues.

Hautin M, Mornet C, Chauveau A, Bernard D, Corcos L, Lippert E Cancers (Basel). 2020; 12(8).

PMID: 32784800 PMC: 7464941. DOI: 10.3390/cancers12082216.


Cytokine receptor splice variants in hematologic diseases.

Wang B, Mehta H Cytokine. 2019; 127:154919.

PMID: 31816579 PMC: 6995764. DOI: 10.1016/j.cyto.2019.154919.